malignant tumor
Conditions
Interventions
blood test, 10 times. brain function test, 4 times.
Sponsors
Kawasaki Medical School
NanoSomiX co.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: First chemotherapy after diagnosis of cancer,
Exclusion criteria
Exclusion criteria: Those who are suffering from serious recognition disorder or psychiatric disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Chemobrain status will be evaluated by cognitive function tests and analyzed for correlation with blood exosome levels and changes. | — |
Countries
Japan
Contacts
Public ContactTakuya Murata
Kawasaki Medical School Obstetrics and Gynecology
Outcome results
None listed